Mifepristone may halt growth of intracranial tumor that causes hearing loss

(Massachusetts Eye and Ear Infirmary) Massachusetts Eye and Ear researchers have shown that mifepristone, a drug currently FDA-approved for chemical abortion, prevents the growth of vestibular schwannoma (also known as acoustic neuroma) cells. This sometimes-lethal intracranial tumor typically causes hearing loss and tinnitus. The findings, published online today in Scientific Reports, suggest that mifepristone is a promising drug candidate to be repositioned for the treatment of these tumors.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news